Cargando…
Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy
Plasminogen activator inhibitor-1 (PAI-1) has a cardioprotective function in mice by repressing cardiac fibrosis through TGF-β and plasminogen-mediated pathways. In addition it is known to be involved in the recruitment and polarization of monocytes/macrophages towards a M2 phenotype in cancer. Here...
Autores principales: | Baumeier, Christian, Escher, Felicitas, Aleshcheva, Ganna, Pietsch, Heiko, Schultheiss, Heinz-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801308/ https://www.ncbi.nlm.nih.gov/pubmed/33432417 http://dx.doi.org/10.1007/s00395-020-00840-w |
Ejemplares similares
-
MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies
por: Aleshcheva, Ganna, et al.
Publicado: (2020) -
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
por: Aleshcheva, Ganna, et al.
Publicado: (2023) -
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021) -
Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection
por: Pietsch, Heiko, et al.
Publicado: (2021) -
Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2022)